177 related articles for article (PubMed ID: 10666509)
1. Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias.
Naito H; Furukawa Y; Chino D; Yamada C; Hashimoto K
Eur J Pharmacol; 2000 Jan; 388(2):171-6. PubMed ID: 10666509
[TBL] [Abstract][Full Text] [Related]
2. Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.
Bril A; Forest MC; Cheval B; Landais L; Gout B
Pharmacology; 1994 May; 48(5):308-19. PubMed ID: 8016191
[TBL] [Abstract][Full Text] [Related]
3. Zatebradine slows ectopic ventricular rhythms in canine heart 24 hours after coronary artery ligation.
Lasker SM; Han D; Kline RP
J Cardiovasc Pharmacol; 1997 May; 29(5):662-9. PubMed ID: 9213210
[TBL] [Abstract][Full Text] [Related]
4. Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias.
Furukawa Y; Xue YX; Chiba S; Hashimoto K
Eur J Pharmacol; 1996 Apr; 300(3):203-10. PubMed ID: 8739209
[TBL] [Abstract][Full Text] [Related]
5. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias.
Ng FS; Shadi IT; Peters NS; Lyon AR
J Mol Cell Cardiol; 2013 Jun; 59():67-75. PubMed ID: 23402927
[TBL] [Abstract][Full Text] [Related]
6. KB-R7943, a Na+/Ca2+ exchange inhibitor, does not suppress ischemia/reperfusion arrhythmias nor digitalis arrhythmias in dogs.
Miyamoto S; Zhu BM; Kamiya K; Nagasawa Y; Hashimoto K
Jpn J Pharmacol; 2002 Nov; 90(3):229-35. PubMed ID: 12499577
[TBL] [Abstract][Full Text] [Related]
7. Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen.
McHugh NA; Cook SM; Schairer JL; Bidgoli MM; Merrill GF
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2569-73. PubMed ID: 7611507
[TBL] [Abstract][Full Text] [Related]
8. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action.
Curtis MJ; Barsby RW; Forster R
J Cardiovasc Pharmacol; 1995 Apr; 25(4):643-51. PubMed ID: 7596134
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic influences on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow.
Euler DE; Wedel VA; Scanlon PJ
J Cardiovasc Pharmacol; 1989 Sep; 14(3):430-7. PubMed ID: 2476623
[TBL] [Abstract][Full Text] [Related]
10. The haemodynamic actions of ZENECA ZD7288, a novel sino-atrial node function modulator, in the exercising beagle: a comparison with zatebradine and propranolol.
Rouse W; Stafford PJ; Johnson IR
Br J Pharmacol; 1994 Nov; 113(3):1071-7. PubMed ID: 7858851
[TBL] [Abstract][Full Text] [Related]
11. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
[TBL] [Abstract][Full Text] [Related]
12. Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog.
Bolli R; Fisher DJ; Taylor AA; Young JB; Miller RR
J Mol Cell Cardiol; 1984 Dec; 16(12):1101-17. PubMed ID: 6152473
[TBL] [Abstract][Full Text] [Related]
13. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
Papp JG; Pollesello P; Varró AF; Végh AS
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290
[TBL] [Abstract][Full Text] [Related]
14. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
15. [Effect of propranolol on dialysate myoglobin levels evoked by ischemia/reperfusion].
Sawada T; Kitagawa H; Nosaka S
Masui; 2013 Nov; 62(11):1351-9. PubMed ID: 24364277
[TBL] [Abstract][Full Text] [Related]
16. Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.
Duce BR; Garberg L; Smith ER
Br J Pharmacol; 1970 Aug; 39(4):809-16. PubMed ID: 4394971
[TBL] [Abstract][Full Text] [Related]
17. Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
Abdel-Kawy HS
Cardiovasc Ther; 2015 Apr; 33(2):27-34. PubMed ID: 25677801
[TBL] [Abstract][Full Text] [Related]
18. Role of oxygen-derived free radicals in canine reperfusion arrhythmias.
Euler DE
Am J Physiol; 1995 Jan; 268(1 Pt 2):H295-300. PubMed ID: 7840275
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
Vegh A; Szekeres L; Parratt J
Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
